| Cell line name |
M1RW5 |
|---|
| Synonyms |
MIRW5 |
|---|
| Accession |
CVCL_4Z12 |
|---|
| Resource Identification Initiative |
To cite this cell line use: M1RW5 (RRID:CVCL_4Z12) |
|---|
| Comments |
Population: Caucasian.
Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072. |
|---|
| Disease |
Melanoma (NCIt: C3224) |
|---|
| Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
|---|
| Hierarchy |
Parent: CVCL_4Z11 (M1RW) |
|---|
| Sex of cell |
Male |
|---|
| Age at sampling |
17Y |
|---|
| Category |
Cancer cell line |
|---|
| Publications | PubMed=6581509; DOI=10.1016/0090-6980(83)90179-X
Bregman M.D., Meyskens F.L. Jr.
In vitro modulation of human and murine melanoma growth by prostanoid analogues.
Prostaglandins 26:449-456(1983) PubMed=3864528
Sipes N.J., Bregman M.D., Meyskens F.L. Jr.
Stimulation of human metastatic melanoma colony-forming cells by an acid-sensitive factor in human platelet sonicate.
Cancer Res. 45:6268-6272(1985) PubMed=3079741; DOI=10.1002/ijc.2910370117
Bregman M.D., Meyskens F.L. Jr.
Difluoromethylornithine enhances inhibition of melanoma cell growth in soft agar by dexamethasone, clone A interferon and retinoic acid.
Int. J. Cancer 37:101-107(1986) PubMed=3698005
Bregman M.D., Funk C., Fukushima M.
Inhibition of human melanoma growth by prostaglandin A, D, and J analogues.
Cancer Res. 46:2740-2744(1986) PubMed=3667379; DOI=10.1016/0360-3016(87)90170-2
Yohem K.H., Bregman M.D., Meyskens F.L. Jr.
Effect of tumor colony definition on ionizing radiation survival curves of melanoma-colony forming cells.
Int. J. Radiat. Oncol. Biol. Phys. 13:1725-1733(1987) |
|---|
| Cross-references |
|---|
| Encyclopedic resources |
Wikidata; Q54903501
|
|---|
| Entry history |
|---|
| Entry creation | 14-Dec-2015 |
|---|
| Last entry update | 29-Jun-2023 |
|---|
| Version number | 7 |
|---|
